Pterygium and Pinguecula: Growths on the Eye Surface

The surface of the eye is not as passive as it looks. Exposed daily to ultraviolet radiation, wind, dust, and particulate matter, the conjunctiva — the clear tissue covering the white of the eye — can respond by building something uninvited. Two of the most common results are pterygium and pinguecula: benign, visually distinctive growths that affect millions of people worldwide, disproportionately in populations with high sun exposure. The World Health Organization has identified UV radiation as a primary environmental risk factor for both conditions, placing them firmly in the category of preventable eye disease.

What Is a Pinguecula?

A pinguecula (pin-GWEK-yoo-lah) is a yellowish, slightly raised deposit that forms on the conjunctiva, almost always on the nasal side of the eye — the side closest to the nose — though it can appear on the temporal side as well. It sits on the conjunctiva itself and does not grow over the cornea.

Histologically, a pinguecula consists of degenerated collagen fibers and, in some cases, calcified deposits or lipid accumulation within the conjunctival stroma. It is not a tumor. It contains no abnormal cells. Think of it as the eye's version of a callus — a localized tissue response to chronic environmental irritation. The National Eye Institute describes pinguecula as among the most frequently encountered benign conjunctival lesions in clinical practice.

Symptoms are often mild: dryness, occasional irritation, a gritty sensation, or cosmetic concern. Inflamed pingueculae — a condition called pingueculitis — can turn red and uncomfortable, particularly after wind or dust exposure.

What Is a Pterygium?

A pterygium (teh-RIJ-ee-um) is a step further. Where a pinguecula stays put, a pterygium advances. It is a fleshy, triangular overgrowth of fibrovascular conjunctival tissue that encroaches onto the cornea — the clear dome at the front of the eye. The word comes from the Greek pterygion, meaning "little wing," and the shape earns the name.

Pterygium originates at the limbus (the border between the cornea and the sclera) and grows toward the center of the cornea. In advanced cases, it can cover the pupil and cause significant vision impairment through irregular astigmatism, corneal distortion, or direct visual axis obstruction. A study published in Ophthalmology (the journal of the American Academy of Ophthalmology) found that pterygium-induced astigmatism can exceed 3 diopters in cases where the growth extends more than 3 mm onto the corneal surface (American Academy of Ophthalmology, EyeWiki).

Pterygium is not just a nuisance. It is a genuine structural alteration of the anterior eye.

Who Gets These Conditions?

Geography matters enormously here. Both conditions are strongly associated with cumulative UV-B exposure, which means prevalence climbs closer to the equator. The "pterygium belt" — a term used in ophthalmic epidemiology — roughly spans the latitudes between 37° North and 37° South. Prevalence rates in equatorial populations can reach 22% or higher, compared to rates below 2% in populations living above 40° latitude (NCBI/PubMed, Pterygium epidemiology review).

Outdoor workers, fishermen, surfers, and farmers carry elevated risk. Dry eye disease appears to compound susceptibility — the corneal surface under chronic desiccation stress may be more reactive to UV-driven conjunctival proliferation. Age is also a factor; both conditions are rare before age 20 and become increasingly common after age 40.

Diagnosis and Differentiation

A slit-lamp examination is the standard diagnostic tool, and for most ophthalmologists, differentiating pterygium from pinguecula is straightforward. The key question: does the growth cross onto the cornea? If yes, pterygium. If it stays on the conjunctiva, pinguecula — at least until proven otherwise.

More important is ruling out what might look similar but is not benign. Conjunctival intraepithelial neoplasia (CIN) and squamous cell carcinoma of the conjunctiva can mimic pterygium clinically. When a lesion appears nodular, highly vascularized, or shows irregular surface texture, biopsy is warranted. The American Academy of Ophthalmology's Preferred Practice Pattern guidelines recommend pathological examination of all excised pterygium tissue.

Treatment Options

Pinguecula rarely needs treatment beyond lubricating eye drops and UV-blocking eyewear. Inflamed cases respond to short courses of topical anti-inflammatory drops — either non-steroidal agents or low-potency corticosteroids. Surgical removal is considered only for persistent cosmetic concern or recurrent inflammation that does not respond to drops.

Pterygium treatment depends on severity. Small, stable pterygia that are not threatening vision are monitored. When growth threatens the visual axis, causes significant astigmatism, or is cosmetically unacceptable to the patient, surgical excision is performed.

The critical surgical concern is recurrence. Bare sclera excision alone — simply cutting the pterygium out — carries recurrence rates as high as 80% in some studies. The current gold standard is conjunctival autograft transplantation, in which conjunctival tissue from the patient's own upper eyelid is sutured or glued (with fibrin adhesive) over the excised area. This technique reduces recurrence rates to below 10% in most published series (NIH/NCBI). Mitomycin C, an antiproliferative agent applied intraoperatively or postoperatively, is used as an adjunct in high-risk recurrence cases.

Prevention

The evidence on prevention is refreshingly unambiguous: UV protection works. Wraparound sunglasses with UV-400 blocking, wide-brimmed hats, and limiting midday outdoor exposure all reduce cumulative corneal UV load. For people who work outdoors — particularly in reflective environments like water or snow — this is not optional advice. It is occupational health strategy.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)